Choice between prostatectomy and radiotherapy when men are eligible for both: A randomized controlled trial of usual care vs decision aid

BJU International

Volumn 111, Issue 4, 2013, Pages 564-573

  Van Tol Geerdink, Julia J ^a   Willem Leer, Jan ^a   Weijerman, Philip C ^b   Van Oort, Inge M ^a   Vergunst, Henk ^c   Van Lin, Emile N ^a   Alfred Witjes, J ^a   Stalmeier, Peep F ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RIJNSTATE HOSPITAL   (Netherlands)

^c CANISIUS WILHELMINA HOSPITAL   (Netherlands)

Author keywords

decision aid; informed choice; patient participation; patient preference; prostate cancer; treatment choice

Indexed keywords

AGE; ARTICLE; BRACHYTHERAPY; CONTROLLED STUDY; ERECTILE DYSFUNCTION; EXTERNAL BEAM RADIOTHERAPY; HUMAN; INTESTINAL DYSMOTILITY; MAJOR CLINICAL STUDY; MALE; PATIENT DECISION MAKING; PATIENT PARTICIPATION; PATIENT PREFERENCE; PATIENT SELECTION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RANDOMIZED CONTROLLED TRIAL; TUMOR CLASSIFICATION; URINARY TRACT DISEASE;

AGED; CHOICE BEHAVIOR; DECISION SUPPORT TECHNIQUES; DISEASE-FREE SURVIVAL; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NETHERLANDS; PATIENT PARTICIPATION; PATIENT PREFERENCE; PATIENT SELECTION; PROGNOSIS; PROSPECTIVE STUDIES; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOTHERAPY, CONFORMAL; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84875840526     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2012.11402.x     Document Type: Article

References (44)

1. Diefenbach MA, Dorsey J, Uzzo RG, et al. Decision-making strategies for patients with localized prostate cancer. Semin Urol Oncol 2002; 20: 55-62
2. Hall JD, Boyd JC, Lippert MC, Theodorescu D,. Why patients choose prostatectomy or brachytherapy for localized prostate cancer: results of a descriptive survey. Urology 2003; 61: 402-407
3. Sommers BD, Beard CJ, D'Amico AV, Kaplan I, Richie JP, Zeckhauser RJ,. Predictors of patient preferences and treatment choices for localized prostate cancer. Cancer 2008; 113: 2058-2067
4. Fowler FJ Jr, McNaughton Collins M, Albertsen PC, Zietman A, Elliott DB, Barry MJ,. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer. JAMA 2000; 283: 3217-3222
5. Heidenreich A, Bellmunt J, Bolla M, et al. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. Eur Urol 2011; 59: 61-71
6. Thompson I, Thrasher JB, Aus G, et al. Guideline for the management of clinically localized prostate cancer: 2007 update. J Urol 2007; 177: 2106-2131
7. van Tol-Geerdink JJ, Stalmeier PF, van, Lin EN, et al. Do prostate cancer patients want to choose their own radiation treatment? Int J Radiat Oncol Biol Phys 2006; 66: 1105-1111
8. van Tol-Geerdink JJ, Leer JW, van, Lin EN, et al. Offering a treatment choice in the irradiation of prostate cancer leads to better informed and more active patients, without harm to well-being. Int J Radiat Oncol Biol Phys 2008; 70: 442-448
9. O'Connor AM, Bennett CL, Stacey D, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev 2009; CD001431. DOI: 10.1002/14651858.CD001431.pub3
10. D'Amico AV, Moul J, Carroll PR, Sun L, Lubeck D, Chen MH,. Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era. J Clin Oncol 2003; 21: 2163-2172
11. Merglen A, Schmidlin F, Fioretta G, et al. Short- and long-term mortality with localized prostate cancer. Arch Intern Med 2007; 167: 1944-1950
12. Albertsen PC, Hanley JA, Penson DF, Barrows G, Fine J,. 13-year outcomes following treatment for clinically localized prostate cancer in a population based cohort. J Urol 2007; 177: 932-936
13. Beyer DC, Thomas T, Hilbe J, Swenson V,. Relative influence of Gleason score and pretreatment PSA in predicting survival following brachytherapy for prostate cancer. Brachytherapy 2003; 2: 77-84
14. Bill-Axelson A, Holmberg L, Ruutu M, et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 2005; 352: 1977-1984
15. Brachman DG, Thomas T, Hilbe J, Beyer DC,. Failure-free survival following brachytherapy alone or external beam irradiation alone for T1-2 prostate tumors in 2222 patients: results from a single practice. Int J Radiat Oncol Biol Phys 2000; 48: 111-117
16. Kupelian PA, Potters L, Khuntia D, et al. Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer. Int J Radiat Oncol Biol Phys 2004; 58: 25-33
17. Roemeling S, Roobol MJ, Postma R, et al. Management and survival of screen-detected prostate cancer patients who might have been suitable for active surveillance. Eur Urol 2006; 50: 475-482
18. Stock RG, Cesaretti JA, Stone NN,. Disease-specific survival following the brachytherapy management of prostate cancer. Int J Radiat Oncol Biol Phys 2006; 64: 810-816
19. Tewari A, Johnson CC, Divine G, et al. Long-term survival probability in men with clinically localized prostate cancer: a case-control, propensity modeling study stratified by race, age, treatment and comorbidities. J Urol 2004; 171: 1513-1519
20. Tward JD, Lee CM, Pappas LM, Szabo A, Gaffney DK, Shrieve DC,. Survival of men with clinically localized prostate cancer treated with prostatectomy, brachytherapy, or no definitive treatment: impact of age at diagnosis. Cancer 2006; 107: 2392-2400
21. Buron C, Le Vu B, Cosset JM, et al. Brachytherapy versus prostatectomy in localized prostate cancer: results of a French multicenter prospective medico-economic study. Int J Radiat Oncol Biol Phys 2007; 67: 812-822
22. Deliveliotis C, Liakouras C, Delis A, Skolarikos A, Varkarakis J, Protogerou V,. Prostate operations: long-term effects on sexual and urinary function and quality of life. Comparison with an age-matched control population. Urol Res 2004; 32: 283-289
23. Hoffman RM, Barry MJ, Stanford JL, Hamilton AS, Hunt WC, Collins MM,. Health outcomes in older men with localized prostate cancer: results from the prostate cancer outcomes study. Am J Med 2006; 119: 418-425
24. Jonler M, Nielsen OS, Wolf H,. Urinary symptoms, potency, and quality of life in patients with localized prostate cancer followed up with deferred treatment. Urology 1998; 52: 1055-1062
25. Korfage IJ, Essink-Bot ML, Borsboom GJJ, et al. Five-year follow-up of health-related quality of life after primary treatment of localized prostate cancer. Int J Cancer 2005; 116: 291-296
26. Lilleby W, Fossa SD, Waehre HR, Olsen DR,. Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy. Int J Radiat Oncol 1999; 43: 735-743
27. Madalinska JB, Essink-Bot ML, de, Koning HJ, Kirkels WJ, van der, Maas PJ, Schroder FH,. Health-related quality-of-life effects of radical prostatectomy and primary radiotherapy for screen-detected or clinically diagnosed localized prostate cancer. J Clin Oncol 2001; 19: 1619-1628
28. McCammon KA, Kolm P, Main B, Schellhammer PF,. Comparative quality-of-life analysis after radical prostatectomy or external beam radiation for localized prostate cancer. Urology 1999; 54: 509-516
29. Miller DC, Sanda MG, Dunn RL, et al. Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy. J Clin Oncol 2005; 23: 2772-2780
30. Penson DF, Feng ZD, Kuniyuki A, et al. General quality of life 2 years following treatment for prostate cancer: what influences outcomes? Results from the prostate cancer outcomes study. J Clin Oncol 2003; 21: 1147-1154
31. Potosky AL, Davis WW, Hoffman RM, et al. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study. J Natl Cancer I 2004; 96: 1358-1367
32. Reis F, Netto NR, Reinato JAS, Thiel M, Zani E,. The impact of prostatectomy and brachytherapy in patients with localized prostate cancer. Int Urol Nephrol 2004; 36: 187-190
33. Schapira MM, Lawrence WF, Katz DA, McAuliffe TL, Nattinger AB,. Effect of treatment on quality of life among men with clinically localized prostate cancer. Med Care 2001; 39: 243-253
34. Schwartz K, Bunner S, Bearer R, Severson RK,. Complications from treatment for prostate carcinoma among men in the Detroit area. Cancer 2002; 95: 82-89
35. ShraderBogen CL, Kjellberg JL, McPherson CP, Murray CL,. Quality of life and treatment outcomes-prostate carcinoma patients' perspectives after prostatectomy or radiation therapy. Cancer 1997; 7: 1977-1986
36. Steineck G, Helgesen F, Adolfsson J, et al. Quality of life after radical prostatectomy or watchful waiting. N Engl J Med 2002; 347: 790-796
37. Talcott JA, Manola J, Clark JA, et al. Time course and predictors of symptoms after primary prostate cancer therapy. J Clin Oncol 2003; 21: 3979-3986
38. Zelefsky MJ, Wallner KE, Ling CC, et al. Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer. J Clin Oncol 1999; 17: 517-522
39. Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG,. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology 2000; 56: 899-905
40. Auvinen A, Hakama M, Ala-Opas M, et al. A randomized trial of choice of treatment in prostate cancer: the effect of intervention on the treatment chosen. BJU Int 2004; 93: 52-56
41. van Tol-Geerdink JJ, Stalmeier PFM, van, Lin ENJT, et al. Do patients with localized prostate cancer treatment really want more aggressive treatment? J Clin Oncol 2006; 24: 4581-4586
42. Gwede CK, Pow-Sang J, Seigne J, et al. Treatment decision-making strategies and influences in patients with localized prostate carcinoma. Cancer 2005; 104: 1381-1390
43. Anandadas CN, Clarke NW, Davidson SE, et al. Early prostate cancer-which treatment do men prefer and why? BJU Int 2011; 107: 1762-1768
44. Zeliadt SB, Ramsey SD, Penson DF, et al. Why do men choose one treatment over another? A review of patient decision making for localized prostate cancer. Cancer 2006; 106: 1865-1874